Skip to main content
. 2013 Nov 26;110(51):20461–20466. doi: 10.1073/pnas.1317002110

Fig. 4.

Fig. 4.

Ligand-binding and dimerization abilities of Toll truncations. All constructs containing at least the N-terminal 399 residues are able to bind Spz C106 according to a range of biophysical techniques. White and gray triangles indicate VLR capping structures, black triangles native Toll N- and C-caps. The Spz construct is represented before and after TEV processing, which leaves an additional glycine residue at the N terminus of C106. The constructs TollN13–VLR and active Spz C106 have been used for crystallography.